- Board member since: 2021
- Independent in relation to the Company and its management: Yes
- Independent in relation to major shareholders: Yes
- Holdings in Alligator: 3,411,884 shares, 100,000 warrants in program TO 2022/2025 II, and 240,000 warrants in program TO 2023/2026 II.
- Other current positions: Chairman of the Board in Ectin Research AB and Improve Tec Hönö AB, board member of RGNT Electric AB, Hoodin AB, Cinda Pharma, Promore Pharma, InorbitTX, S.P. HMSO AB, Oblique Therapeutics AB and Lennart Ekerholms Stiftelse. Deputy board member in O Mgmt AB.
Hans-Peter Ostler – born 1971, Vice chairman since 2021 – has University studies in economics and law etc. at the School of Business, Economics and Law and School of Public Administration at Gothenburg University and currently works as wealth manager at Söderberg & Partners. Hans-Peter Ostler has more than 20 years of experience in investment banking and private banking, including from Danske Bank. Hans-Peter Ostler’s previous experiences include assignments such as board member of IRLAD Therapeutics AB.